Testing effectiveness (Phase 2)Study completedNCT02836574
What this trial is testing
Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 83